Comparing Features of In Situ and Invasive Breast Carcinoma
Author Information
Author(s): Naimi Azar, Niloufar Mohaghegh
Primary Institution: Isfahan University of Medical Sciences
Hypothesis
This study aims to examine the similarities or differences in structural, cytological, and immunohistochemical features between in situ and invasive components of breast carcinoma.
Conclusion
The study found differences in biomarker expression between in situ and invasive breast carcinoma components, suggesting that in situ components may not accurately represent invasive components for treatment decisions.
Supporting Evidence
- 70.6% of cases showed high grade in both in situ and invasive carcinoma.
- ER.PR was positive in 74.5% of both in situ and invasive carcinoma types.
- 45.1% of in situ carcinoma cases had a solid structure.
Takeaway
This study looked at breast cancer and found that the early stage (in situ) and the later stage (invasive) can show different characteristics, which is important for deciding how to treat the cancer.
Methodology
A cross-sectional study examining 51 samples of breast cancer with both in situ and invasive components, using immunohistochemical analysis.
Limitations
The study's findings may not be generalizable due to the small sample size and the specific population studied.
Participant Demographics
Patients aged 27 to 74 years, with a mean age of 48.78 years, primarily from the age group of 51-60 years.
Statistical Information
P-Value
P=0.687 for grade comparison, P=1.00 for ER.PR comparison, P=0.180 for Ki67 comparison, P=0.532 for Her2 comparison.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website